Institutional investors purchased a net $443.9 thousand shares of BSTC during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 60.64% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANZ GLOBAL INVESTORS U.S. LL... Bought 97.9 Thousand shares of Biospecifics Technologies...